Phoenix Financial Ltd. cut its stake in shares of NICE Ltd. (NASDAQ:NICE - Free Report) by 20.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,449,397 shares of the technology company's stock after selling 361,600 shares during the period. NICE accounts for about 3.5% of Phoenix Financial Ltd.'s portfolio, making the stock its 5th biggest position. Phoenix Financial Ltd. owned about 2.31% of NICE worth $253,801,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also modified their holdings of the stock. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in NICE in the fourth quarter worth $313,808,000. FIL Ltd bought a new stake in shares of NICE in the 4th quarter worth about $70,465,000. New South Capital Management Inc. purchased a new position in shares of NICE during the 4th quarter worth about $54,980,000. Perpetual Ltd purchased a new position in shares of NICE during the 4th quarter worth about $31,792,000. Finally, Raymond James Financial Inc. bought a new position in NICE during the 4th quarter valued at about $26,810,000. 63.34% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several research analysts have issued reports on NICE shares. Royal Bank of Canada restated an "outperform" rating and set a $200.00 target price on shares of NICE in a research report on Wednesday, March 19th. Jefferies Financial Group restated a "hold" rating and set a $200.00 price objective (down from $215.00) on shares of NICE in a report on Thursday, December 19th. Barclays dropped their price target on NICE from $286.00 to $226.00 and set an "overweight" rating on the stock in a research report on Friday, February 21st. Cantor Fitzgerald cut their price target on NICE from $176.00 to $161.00 and set a "neutral" rating on the stock in a research note on Friday, February 21st. Finally, Rosenblatt Securities lowered their price objective on shares of NICE from $225.00 to $200.00 and set a "buy" rating for the company in a research note on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $228.43.
Get Our Latest Stock Report on NICE
NICE Stock Performance
Shares of NICE stock traded up $2.38 during trading on Tuesday, hitting $155.00. 155,006 shares of the company's stock were exchanged, compared to its average volume of 582,000. NICE Ltd. has a 52-week low of $137.19 and a 52-week high of $236.48. The stock has a market capitalization of $9.75 billion, a price-to-earnings ratio of 22.93, a PEG ratio of 1.07 and a beta of 1.05. The business has a 50-day simple moving average of $154.94 and a 200-day simple moving average of $167.88.
NICE (NASDAQ:NICE - Get Free Report) last issued its earnings results on Thursday, February 20th. The technology company reported $2.25 EPS for the quarter, missing analysts' consensus estimates of $2.96 by ($0.71). NICE had a return on equity of 16.17% and a net margin of 16.18%. The company had revenue of $721.60 million during the quarter, compared to analysts' expectations of $718.47 million. On average, equities analysts anticipate that NICE Ltd. will post 9.85 earnings per share for the current fiscal year.
NICE Company Profile
(
Free Report)
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
See Also

Before you consider NICE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NICE wasn't on the list.
While NICE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.